← Back to all recallsDRUG RECALL
Cetirizine Hydrochloride Tablets 5 mg
Rising Pharma recalls Cetirizine HCl 5 mg tablets over Ranitidine cross-contamination.
What to do
Check your bottle for NDC 16571-401-10. Do not use the tablets; return them to the place of purchase for a refund or replacement.
Why it was recalled
Rising Pharma Holdings is recalling Cetirizine Hydrochloride Tablets USP 5 mg, 100-count bottles, due to cross-contamination with Ranitidine. Customer complaints reported discolored tablets and red dots on the product.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
Cetirizine Hydrochloride Tablets USP
- Strength
- 5 mg
- NDC / UPC
- NDC 16571-401-10
Official source
Other recent recalls from JB Chemicals and Pharmaceuticals Ltd
Editorial summary by Recall Canary · last updated 2026-07-24 · primary source: U.S. Food and Drug Administration